As for human breast cancer, back in 2010 Rao et al. [195] reported that panobinostat inhibits HDAC6 in cultured MCF-7 and MDA-MB-231 cells, thereby increasing the acetylation of GRP78 in 11 lysine residues. Here, HSPA5 is linked to breast carcinoma.